ALK and lung carcinoma: In 2007, Soda et al. and Rikova et al. identified a fusion gene in lung cancer cells containing an inversion of the echinoderm microtubule-associated protein-like 4 (EML4) with the anaplastic lymphoma kinase (ALK) that possesses oncogenic activity and can serve as a therapeutic target1,2.